CAP TODAY Pathology/Laboratory Medicine/Laboratory Management
Dec. 18, 2018—Siemens Healthineers has been granted 12 premarket approvals from the FDA for its infectious disease and oncology testing menu.
“These 12 PMA assays, combined with recently released High-Sensitivity Troponin I and Procalcitonin assays, provide a comprehensive menu on the Atellica Solution. Laboratories seeking a broad menu supporting the needs of their clinicians and patients can now find it on the Atellica Solution,” Deepak Nath, PhD, president of laboratory diagnostics at Siemens Healthineers, said in a statement.
Pages: 1 2